Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt–Jakob disease: correlation with clinical course
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Jae Hyoung Kim & Byung Se Choi & Cheolkyu Jung & YoungHee Chang & SangYun Kim
- چاپ و سال / کشور: 2010
Description
Introduction Sporadic Creutzfeldt–Jakob disease (sCJD) is a fatal disease with variable clinical courses. The presence or absence of basal ganglia (BG) involvement has been reported to be associated with clinical course. We investigated the association of clinical course of sCJD with diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as well as BG involvement at early stage. Methods DWI and single voxel proton MRS were performed in 14 patients with sCJD during the initial diagnostic workup. Apparent diffusion coefficient (ADC) and metabolites were measured in medial occipitoparietal cortices where large hyperintense DWI lesions were found in all patients. The presence or absence of BG involvement, ADC, N-acetylaspartate (NAA)/creatine (Cr) ratios, and choline (Cho)/Cr ratios were correlated with disease duration (i.e., the time from the symptom onset to death). Results The disease duration ranged from 2 to 31 months (median, 16). Hyperintense DWI lesions were observed bilaterally in both cortices and basal ganglia in eight patients and in cortices alone in six patients. Patients with BG involvement had shorter disease duration (median, 6.8 versus 20.5; p=0.039) than those without and lower NAA/ Cr ratios (median, 1.41 versus 2.03; p=0.001). ADC and Cho/Cr ratios were not significantly different between the patients with BG involvement and those without. By multiple regression analysis, NAA/Cr ratios had the greatest correlation with the disease duration (p=0.029). Conclusion The disease duration of sCJD was variable. NAA/ Cr ratios of the affected brain at the early stage of sCJD can be used as a useful parameter in predicting the clinical course
Neuroradiology DOI 10.1007/s00234-010-0820-4 Received: 22 July 2010 / Accepted: 1 December 2010
